Literature DB >> 26069289

LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic application.

Margot J Pont1, Willemijn Hobo2, Maria W Honders3, Simone A P van Luxemburg-Heijs3, Michel G D Kester3, Annemarie M van Oeveren-Rietdijk4, Nicolaas Schaap5, Hetty C de Boer4, Cornelis A M van Bergen3, Harry Dolstra2, J H Frederik Falkenburg3, Marieke Griffioen3.   

Abstract

Keywords:  LB-ARHGDIB-IR; hematopoiesis-restricted expression; minor histocompatibility antigen

Mesh：

Substances：

Year:  2015        PMID： 26069289      PMCID： PMC4591780          DOI： 10.3324/haematol.2015.125021

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Interferon-gamma rapidly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells.

Authors:  W Ma; P J Lehner; P Cresswell; J S Pober; D R Johnson
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

2.  cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins.

Authors:  J M Lelias; C N Adra; G M Wulf; J C Guillemot; M Khagad; D Caput; B Lim
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

3.  Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes.

Authors:  P Scherle; T Behrens; L M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 4.  Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.

Authors:  Marie Bleakley; Stanley R Riddell
Journal:  Immunol Cell Biol       Date:  2011-02-08       Impact factor: 5.126

5.  High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning.

Authors:  Cornelis A M Van Bergen; Caroline E Rutten; Edith D Van Der Meijden; Simone A P Van Luxemburg-Heijs; Ellie G A Lurvink; Jeanine J Houwing-Duistermaat; Michel G D Kester; Arend Mulder; Roel Willemze; J H Frederik Falkenburg; Marieke Griffioen
Journal:  Cancer Res       Date:  2010-11-09       Impact factor: 12.701

Review 6.  RhoGDI2 as a therapeutic target in cancer.

Authors:  Hee Jun Cho; Kyoung Eun Baek; Jiyun Yoo
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

7.  Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer.

Authors:  Dan Theodorescu; L M Sapinoso; M R Conaway; G Oxford; G M Hampton; H F Frierson
Journal:  Clin Cancer Res       Date:  2004-06-01       Impact factor: 12.531

Review 8.  Graft-versus-leukemia effects of transplantation and donor lymphocytes.

Authors:  Hans-Jochem Kolb
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

9.  Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations.

Authors:  Faviel F Gonzalez-Galarza; Stephen Christmas; Derek Middleton; Andrew R Jones
Journal:  Nucleic Acids Res       Date:  2010-11-09       Impact factor: 16.971

10.  Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations.

Authors:  Eric Spierings; Matthijs Hendriks; Léna Absi; Angelica Canossi; Sonal Chhaya; John Crowley; Harry Dolstra; Jean-François Eliaou; Tom Ellis; Jürgen Enczmann; Maria E Fasano; Thibaut Gervais; Clara Gorodezky; Brigitte Kircher; David Laurin; Mary S Leffell; Pascale Loiseau; Mari Malkki; Miroslaw Markiewicz; Miryam Martinetti; Etsuko Maruya; Narinder Mehra; Fatma Oguz; Machteld Oudshoorn; Noemi Pereira; Rajni Rani; Ruhena Sergeant; Jackie Thomson; Thuong Hien Tran; Hannu Turpeinen; Kuo-Liang Yang; Renata Zunec; Mary Carrington; Peter de Knijff; Els Goulmy
Journal:  PLoS Genet       Date:  2007-06       Impact factor: 5.917
View more
  8 in total

Review 1.  Personal tumor antigens in blood malignancies: genomics-directed identification and targeting.

Authors:  Livius Penter; Catherine J Wu
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 2.  Allo-reactive T cells for the treatment of hematological malignancies.

Authors:  J H F Falkenburg; I Jedema
Journal:  Mol Oncol       Date:  2015-10-24       Impact factor: 6.603

3.  Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies.

Authors:  M J Pont; M W Honders; A N Kremer; C van Kooten; C Out; P S Hiemstra; H C de Boer; M J Jager; E Schmelzer; R G Vries; A S Al Hinai; W G Kroes; R Monajemi; J J Goeman; S Böhringer; W A F Marijt; J H F Falkenburg; M Griffioen
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

Review 4.  Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets.

Authors:  Marieke Griffioen; Cornelis A M van Bergen; J H Frederik Falkenburg
Journal:  Front Immunol       Date:  2016-03-15       Impact factor: 7.561

5.  CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.

Authors:  Peter van Balen; Cornelis A M van Bergen; Simone A P van Luxemburg-Heijs; Wendy de Klerk; Esther H M van Egmond; Sabrina A J Veld; Constantijn J M Halkes; Jaap-Jan Zwaginga; Marieke Griffioen; Inge Jedema; J H Frederik Falkenburg
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

6.  Antibodies against ARHGDIB are associated with long-term kidney graft loss.

Authors:  Elena G Kamburova; Maartje L Gruijters; Tineke Kardol-Hoefnagel; Bram W Wisse; Irma Joosten; Wil A Allebes; Arnold van der Meer; Luuk B Hilbrands; Marije C Baas; Eric Spierings; Cornelis E Hack; Franka E van Reekum; Arjan D van Zuilen; Marianne C Verhaar; Michiel L Bots; Adriaan C A D Drop; Loes Plaisier; Rowena C A Melchers; Marc A J Seelen; Jan Stephan Sanders; Bouke G Hepkema; Annechien J A Lambeck; Laura B Bungener; Caroline Roozendaal; Marcel G J Tilanus; Christina E Voorter; Lotte Wieten; Elly M van Duijnhoven; Mariëlle A C J Gelens; Maarten H L Christiaans; Frans J van Ittersum; Shaikh A Nurmohamed; Neubury M Lardy; Wendy Swelsen; Karlijn A M I van der Pant; Neelke C van der Weerd; Ineke J M Ten Berge; Andries Hoitsma; Paul J M van der Boog; Johan W de Fijter; Michiel G H Betjes; Sebastiaan Heidt; Dave L Roelen; Frans H Claas; Frederike J Bemelman; Henny G Otten
Journal:  Am J Transplant       Date:  2019-07-03       Impact factor: 8.086

Review 7.  The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction.

Authors:  Tuna Mutis; Anastasia Xagara; Robbert M Spaapen
Journal:  Front Immunol       Date:  2020-06-24       Impact factor: 7.561

8.  HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.

Authors:  Peter van Balen; Inge Jedema; Marleen M van Loenen; Renate de Boer; H M van Egmond; Renate S Hagedoorn; Conny Hoogstaten; Sabrina A J Veld; Lois Hageman; P A G van Liempt; Jaap-Jan Zwaginga; Pauline Meij; H Veelken; J H F Falkenburg; Mirjam H M Heemskerk
Journal:  Front Immunol       Date:  2020-08-20       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.